We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
This study reported high prevalence, especially of undiagnosed cases amongst adults, most have uncontrolled blood sugar levels
Advice for medical professionals to follow when assessing drivers with diabetes mellitus.
This study showed high levels of stress in more than one third of diabetes mellitus (DM) patients
Background information and advice on coronavirus (COVID-19) for health and care professionals.
This paper describes the relationship between obesity and diabetes to support public health policy makers and practitioners.
This study aims to identify the reasons for not undergoing confirmation by those at high risk for developing diabetes
A Randomised Controlled Trial in a Nigerian Tertiary Care Hospital
How to use an interrupted time series to evaluate your digital health product.
The characteristics, diagnosis, treatment, and epidemiology of group B streptococci.
For the first time in the UK, obese patients and people who are overweight with weight-related health problems could now have access to Mounjaro, currently used for Type 2 diabetes, to help manage their weight and support weight loss.
Analysis of risk factors for pre-diabetes (also called non-diabetic hyperglycaemia, or NDH) and undiagnosed type 2 diabetes among adults.
Analysis of risk factors for pre-diabetes (also called non-diabetic hyperglycaemia, or NDH) and undiagnosed type 2 diabetes among adults living in private households, using the Health Survey for England 2013 to 2019.
This trial was conducted during routine outpatient department hours in a primary health care setting in Puducherry, India
The new presentation of Mounjaro gives four doses for once-a-week treatment over a month.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).